Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Blood Adv
.
2024 Sep 24:bloodadvances.2024013696.
doi: 10.1182/bloodadvances.2024013696.
Online ahead of print.
Authors
Paul G Kemps
1
,
F J Sherida H Woei-A-Jin
2
,
Koen D Quint
3
,
Cor van den Bos
4
,
Leonie Naeije
5
,
Jan Am van Laar
6
,
Isabelle Vanden Bempt
7
,
Marco J Koudijs
5
,
Ruben Harmen Paul Vorderman
1
,
Ellen Stelloo
8
,
Joost F Swennenhuis
9
,
Annette H Bruggink
10
,
Konnie M Hebeda
11
,
Marijn A Scheijde-Vermeulen
5
,
Gilles Fh Diercks
12
,
Robert M Verdijk
13
,
Patty M Jansen
1
,
Esther Hauben
14
,
Thomas Tousseyn
15
,
Arjen Hg Cleven
12
,
Tom van Wezel
1
,
Astrid G S van Halteren
16
,
Pancras C W Hogendoorn
1
Affiliations
1
Leiden University Medical Center, Leiden, Netherlands.
2
University Hospitals Leuven, KU Leuven, Leuven, Belgium.
3
Leiden University Medical Center, 2333 ZA, Netherlands.
4
Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
5
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
6
Erasmus University Medical Center, rotterdam, Netherlands.
7
University Hospitals Leuven, Leuven, Belgium.
8
Solvias NL (formerly Cergentis bv), Utrecht, Netherlands.
9
Cergentis BV, Utrecht, Netherlands.
10
Palga (Dutch Nationwide Pathology Databank), Houten, Netherlands.
11
Radboudumc, Nijmegen, Netherlands.
12
University Medical Center Groningen, Groningen, Netherlands.
13
Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
14
UZ Leuven, University Hospitals, Leuven, Belgium.
15
KU Leuven, Leuven, Belgium.
16
Erasmus Medical Center, Rotterdam, Netherlands.
PMID:
39361730
DOI:
10.1182/bloodadvances.2024013696
No abstract available